Zimmer Biomet Holdings Debt to Equity Ratio 2006-2018 | ZBH
Current and historical debt to equity ratio values for Zimmer Biomet Holdings (ZBH) over the last 10 years.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.003B | $7.824B |
| Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $119.342B | 18.47 |
| Abbott Laboratories (ABT) | United States | $110.100B | 24.06 |
| Stryker (SYK) | United States | $65.814B | 26.32 |
| Boston Scientific (BSX) | United States | $46.845B | 26.11 |
| Baxter (BAX) | United States | $40.028B | 28.64 |
| ResMed (RMD) | United States | $15.613B | 32.65 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.557B | 0.00 |
| Perrigo (PRGO) | Ireland | $10.804B | 15.15 |
| Bio-Rad Laboratories (BIO) | United States | $9.019B | 72.75 |
| Hill-Rom Holdings (HRC) | United States | $6.245B | 22.44 |
| ICU Medical (ICUI) | United States | $6.025B | 56.06 |
| Canopy Growth (CGC) | Canada | $5.716B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $5.207B | 0.00 |
| Insulet (PODD) | United States | $5.132B | 0.00 |
| Haemonetics (HAE) | United States | $5.062B | 52.13 |
| Neogen (NEOG) | United States | $4.333B | 69.28 |
| Hutchison China MediTech (HCM) | China | $4.232B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.064B | 0.00 |
| National Vision Holdings (EYE) | United States | $3.032B | 0.00 |
| NuVasive (NUVA) | United States | $2.737B | 27.66 |
| Quidel (QDEL) | United States | $2.658B | 116.31 |
| Phibro Animal Health (PAHC) | United States | $1.942B | 28.83 |
| Abaxis,Inc (ABAX) | United States | $1.906B | 64.11 |
| NxStage Medical (NXTM) | United States | $1.865B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.414B | 21.78 |
| Eagle Pharmaceuticals (EGRX) | United States | $1.216B | 34.02 |
| Cardiovascular Systems (CSII) | United States | $1.173B | 0.00 |
| Orthofix (OFIX) | $1.089B | 33.18 | |
| Owens & Minor (OMI) | United States | $1.074B | 10.80 |
| AtriCure (ATRC) | United States | $1.026B | 0.00 |
| OraSure Technologies (OSUR) | United States | $1.020B | 61.89 |
| Cerus (CERS) | United States | $0.967B | 0.00 |
| Omeros (OMER) | United States | $0.954B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.936B | 0.00 |
| MacroGenics (MGNX) | United States | $0.915B | 0.00 |
| Surmodics (SRDX) | United States | $0.784B | 134.32 |
| LeMaitre Vascular (LMAT) | United States | $0.709B | 41.69 |
| Meridian Bioscience (VIVO) | United States | $0.669B | 23.58 |
| PetIQ (PETQ) | United States | $0.639B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.571B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.536B | 14.00 |
| Evolus (EOLS) | United States | $0.528B | 0.00 |
| Surface Oncology (SURF) | United States | $0.416B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.364B | 24.11 |
| Cytosorbents (CTSO) | United States | $0.362B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.328B | 0.00 |
| Quanterix (QTRX) | United States | $0.326B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.289B | 0.00 |
| Chimerix (CMRX) | United States | $0.226B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.223B | 0.00 |
| Fonar (FONR) | United States | $0.173B | 10.48 |
| Bovie Medical (BVX) | United States | $0.168B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.158B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.136B | 0.00 |
| Female Health (VERU) | United States | $0.115B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.104B | 31.00 |
| Oramed Pharmaceuticals (ORMP) | Israel | $0.099B | 0.00 |
| United-Guardian (UG) | United States | $0.089B | 20.91 |
| Neurotrope (NTRP) | United States | $0.087B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.074B | 0.00 |
| CAS Medical Systems (CASM) | United States | $0.057B | 0.00 |
| Imprimis Pharmaceuticals (IMMY) | United States | $0.047B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.041B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.034B | 0.00 |
| Myomo (MYO) | United States | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.026B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.010B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.003B | 0.00 |
